Analysts at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the software maker’s stock.
Separately, Stephens increased their price objective on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
Read Our Latest Report on MDRX
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- Why Invest in High-Yield Dividend Stocks?
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- What Does a Stock Split Mean?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- 5 discounted opportunities for dividend growth investors
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
